Table 5 |
||
|
Differences of treatment effect and standardized response means of rheumatoid arthritis disease activity and function outcomes between baseline and month 3 of treatment |
||
|
Rheumatoid arthritis outcome |
Mean difference of treatment (95% CI) |
SRM (95% CI) |
|
|
||
|
Tender joint count |
-3.58 (-2.42 to -4.74) |
0.59 (0.40 to 0.78) |
|
Swollen joint count |
-2.72 (-1.90 to -3.53) |
0.64 (0.45 to 0.83) |
|
Patient global assessment |
-0.79 (-0.63 to -0.96) |
0.94 (0.74 to 1.13) |
|
Physician global assessment |
-0.77 (-0.61 to -0.94) |
0.89 (0.70 to 1.09) |
|
Pain level |
-0.75 (-0.58 to -0.93) |
0.82 (0.62 to 1.01) |
|
ESR |
-13.93 (-7.01 to -20.84) |
0.41 (0.21 to 0.61) |
|
Thai HAQ |
-0.50 (-0.38 to -0.63) |
0.75 (0.56 to 0.94) |
|
ACR functional class |
-0.44 (-0.29 to -0.60) |
0.59 (0.38 to 0.80) |
|
|
||
|
ACR, American College of Rheumatology; CI, confidence interval; ESR, erythrocyte sedimentation rate; SRM, standardized response mean; Thai HAQ, Thai version of the Health Assessment Questionnaire Disability Index. |
||
|
Osiri et al. Arthritis Research & Therapy 2009 11:R129 doi:10.1186/ar2796 |
||